Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

Similar articles for PubMed (Select 23583828)

1.

Efficacy and long-term outcome of treatment for pure red cell aplasia after allogeneic stem cell transplantation from major ABO-incompatible donors.

Hirokawa M, Fukuda T, Ohashi K, Hidaka M, Ichinohe T, Iwato K, Kanamori H, Murata M, Sakura T, Imamura M, Adachi S, Suzuki R, Morishima Y, Sakamaki H; PRCA Collaborative Study Group.

Biol Blood Marrow Transplant. 2013 Jul;19(7):1026-32. doi: 10.1016/j.bbmt.2013.04.004. Epub 2013 Apr 10.

2.
3.

Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.

Helbig G, Stella-Holowiecka B, Wojnar J, Krawczyk M, Krzemien S, Wojciechowska-Sadus M, Markiewicz M, Wylezol I, Kopera M, Holowiecki J.

Ann Hematol. 2007 Sep;86(9):677-83. Epub 2007 May 8.

PMID:
17486341
4.

Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.

Helbig G, Stella-Holowiecka B, Krawczyk-Kulis M, Wojnar J, Markiewicz M, Wojciechowska-Sadus M, Kopera M, Kruzel T, Najda J, Nowak K, Holowiecki J.

Haematologica. 2005 Nov;90 Suppl:ECR33.

5.

[Pure red cell aplasia following ABO-incompatible allogeneic hematopoietic stem cell transplantation].

Fan H, Jing Y, Li HH, Lu XC, Yu L.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Apr;16(2):364-7. Chinese.

PMID:
18426666
6.

[Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation].

Huang XJ, Liu DH, Xu LP, Han W, Jiang Q, Chen YH, Zhang YC, Liu KY, Bao L, Lu DP.

Zhonghua Xue Ye Xue Za Zhi. 2005 Sep;26(9):548-50. Chinese.

PMID:
16468333
7.

Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption.

Rabitsch W, Knöbl P, Prinz E, Keil F, Greinix H, Kalhs P, Worel N, Jansen M, Hörl WH, Derfler K.

Bone Marrow Transplant. 2003 Nov;32(10):1015-9.

PMID:
14595389
8.

Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation.

Aung FM, Lichtiger B, Bassett R, Liu P, Alousi A, Bashier Q, Ciurea SO, de Lima MJ, Hosing C, Kebriaei P, Nieto Y, Oran B, Parmar S, Qazilbash M, Shah N, Khouri I, Champlin RE, Popat U.

Br J Haematol. 2013 Mar;160(6):798-805. doi: 10.1111/bjh.12210. Epub 2013 Jan 18.

9.

Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins.

Stussi G, Halter J, Bucheli E, Valli PV, Seebach L, Gmür J, Gratwohl A, Schanz U, Passweg JR, Seebach JD.

Haematologica. 2009 Feb;94(2):239-48. doi: 10.3324/haematol.13356. Epub 2009 Jan 14.

10.

Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.

Zhu KE, Xu Y, Wu D, Zhong J.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2002 Feb;10(1):61-5.

PMID:
12513840
11.
12.
13.

Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.

Ozkurt ZN, Yegin ZA, Yenicesu I, Aki SZ, Yagci M, Sucak GT.

Transplant Proc. 2009 Nov;41(9):3851-8. doi: 10.1016/j.transproceed.2009.06.189.

PMID:
19917400
14.

Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.

Mueller RJ, Stussi G, Odermatt B, Halter J, Schanz U, Seebach JD.

Xenotransplantation. 2006 Mar;13(2):126-32.

PMID:
16623806
15.

[Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].

Bullorsky E, Shanley C, Stemmelin G, Ceresetto J, Rabinovich O.

Medicina (B Aires). 2002;62(6):575-7. Spanish.

PMID:
12532694
16.

Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation.

Fang B, Song Y, Li N, Li J, Han Q, Zhao RC.

Ann Hematol. 2009 Mar;88(3):261-6. doi: 10.1007/s00277-008-0599-0. Epub 2008 Sep 4.

PMID:
18769919
17.

Changes of isoagglutinin titres after ABO-incompatible allogeneic stem cell transplantation.

Lee JH, Lee JH, Choi SJ, Kim S, Seol M, Kwon SW, Park CJ, Chi HS, Lee JS, Kim WK, Lee KH.

Br J Haematol. 2003 Feb;120(4):702-10.

PMID:
12588361
18.

Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk.

Dahl D, Hahn A, Koenecke C, Heuft HG, Dammann E, Stadler M, Buchholz S, Krauter J, Eder M, Sykora KW, Klein C, Ganser A, Sauer M.

Transfusion. 2010 Mar;50(3):649-55. doi: 10.1111/j.1537-2995.2009.02461.x. Epub 2009 Nov 19.

PMID:
19929861
19.

Outcomes after major or bidirectional ABO-mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor-type secretor plasma with or without plasma exchange.

Curley C, Pillai E, Mudie K, Western R, Hutchins C, Durrant S, Kennedy GA.

Transfusion. 2012 Feb;52(2):291-7. doi: 10.1111/j.1537-2995.2011.03295.x. Epub 2011 Aug 16.

PMID:
21848968
20.

Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation.

Bolan CD, Leitman SF, Griffith LM, Wesley RA, Procter JL, Stroncek DF, Barrett AJ, Childs RW.

Blood. 2001 Sep 15;98(6):1687-94.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk